Minneapolis-based Allina Health announced Aug. 23 that it is ending a billing and collection policy that drew national attention and an investigation by the the Minnesota attorney general.
The FDA warned Amazon, Walmart and two other companies for selling products for molluscum contagiosum — a viral skin infection that does not have any approved over-the-counter treatments.
Houston-based Texas Heart Institute received a grant to develop a first-in-class drug for cardiovascular disease and received $32 million from a patient.
The American Hospital Association stated its opposition to a drafted July 28 proposal from the U.S. House Energy and Commerce Committee that could lead to limit access to the 340B Drug Pricing Program in an Aug. 22 letter.
More than 97 percent of health systems and hospitals said the shortage of carboplatin, a bladder cancer drug, is affecting pharmacy operations and patient care, according to a survey conducted by Vizient.
The University of Michigan Health is restructuring its executive team to oversee operations at the University of Michigan Health-West in Wyoming, Mich., and Lansing-based Sparrow Health, a six-hospital system that it acquired in April.